Euphorbium compositum SN
Natural health product licensed in Canada
- Licence holder
- Biologische Heilmittel Heel GmbH
- NPN or DIN-HM
- 80029115
- Status
- Inactive licence
- Licence date
- 20 January 2012
- Revision date
- 21 July 2013
- Form
- Pulvérisateur nasal (solution)
- Route of administration
- Nasale
- Application type
- Homéopathique
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Hepar sulfuris calcareum Source : Soufre Potency : 1 g D 10 | 10 D |
| Hepar sulfuris calcareum Source : Calcium carbonicum Hahnemanni Potency : 1 g D 10 | 10 D |
| Euphorbium Source : Hardened latex from Euphorbia resinifera Potency : 1 g D 4 | 4 D |
| Luffa operculata Source : Fruit séché Potency : 1 g D 2 | 2 D |
| Pulsatilla Source : Plante entière fleurie fraîche Potency : 1 g D 2 | 2 D |
| Pulsatilla Source : pulsatilla pratensis (L.) Mill Potency : 1 g D 2 | 2 D |
Non-medicinal ingredients
phosphate monobasique de sodium (dihydrate), Chlorure de sodium, Phosphate de calcium dibasique dihydraté, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 6 years | 1 Pulvérisateur | 3 Tous les jours |
| Adultes | minimum: 12 years | minimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 8 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 1 Pulvérisateur | 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 1 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 6 Tous les jours |
| Adultes | minimum: 12 years | minimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateur | 3 Tous les jours |
| Enfants | minimum: 2 years ; maximum: 6 years | 1 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Homeopathic preparation to treat the symptoms of acute and chronic rhinitis and sinusitis such as inflammation, headache, sneezing, runny or stuffy nose, nasal redness and soreness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029115
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging